Capital Research Global Investors Portfolio holdings
Capital Research Global Investors (CRGI), a division of Capital Group established in 1931 and headquartered in Los Angeles, California, is a powerhouse in active investment management, overseeing hundreds of billions in assets with a focus on global equity portfolios. Known for its long-term, research-intensive approach, CRGI employs a unique multiple-portfolio-manager system to diversify risk and enhance returns, serving institutional clients, financial advisors, and individual investors through vehicles like the American Funds mutual fund family. The firm’s investment philosophy emphasizes fundamental analysis and a deep understanding of companies worldwide, aiming to identify growth opportunities over extended horizons. As part of Capital Group’s broader mission, CRGI has built a reputation for delivering consistent, value-driven results in the global investment landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$5.5B |
| 2 |
UBS Group
UBS
|
+$1.65B |
| 3 |
JPMorgan Chase
JPM
|
+$1.33B |
| 4 |
Goldman Sachs
GS
|
+$976M |
| 5 |
Teva Pharmaceuticals
TEVA
|
+$939M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$2.02B |
| 2 |
Digital Realty Trust
DLR
|
+$1.33B |
| 3 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$981M |
| 4 |
AET
Aetna Inc
AET
|
+$831M |
| 5 |
Texas Instruments
TXN
|
+$815M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.85% |
| 2 | Technology | 13.64% |
| 3 | Financials | 11.28% |
| 4 | Communication Services | 10.33% |
| 5 | Energy | 10.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
KITE
201
DELISTED
Kite Pharma, Inc.
KITE
| $274M | 0.09% |
6,109,771
+34,148
| +0.6% | +$1.68M |
|
|
AVP
202
DELISTED
Avon Products, Inc.
AVP
| $269M | 0.09% |
53,358,441
+5,025
| +0% | +$29.2K |
|
203
Golar LNG
GLNG
$5.27B
| $269M | 0.09% |
11,706,182
+308,000
| +3% | +$7.16M |
|
204
Texas Roadhouse
TXRH
$14B
| $264M | 0.09% |
5,478,146
+100,000
| +2% | +$4.4M |
|
|
IOC
205
DELISTED
Interoil Corporation
IOC
| $263M | 0.09% |
5,533,740
-1,989
| -0% | -$97.1K |
|
206
American Tower
AMT
$80.6B
| $261M | 0.08% |
2,472,467
+703,968
| +40% | +$76.5M |
|
|
ENDP
207
DELISTED
Endo International plc
ENDP
| $258M | 0.08% |
+15,671,728
| New | +$276M |
|
208
Public Storage
PSA
$61B
| $252M | 0.08% |
1,126,000
| – | – |
|
209
SM Energy
SM
$7.6B
| $250M | 0.08% |
7,245,940
| – | – |
|
210
Lumentum
LITE
$83.7B
| $249M | 0.08% |
6,442,534
-536
| -0% | -$21.3K |
|
211
Williams-Sonoma
WSM
$29B
| $243M | 0.08% |
10,052,012
| – | – |
|
212
Ford
F
$55.6B
| $243M | 0.08% |
+20,000,000
| New | +$243M |
|
213
Melco Resorts & Entertainment
MLCO
$2.16B
| $241M | 0.08% |
15,175,776
-4,538,283
| -23% | -$77.9M |
|
214
Webster Financial
WBS
$12.8B
| $239M | 0.08% |
4,401,999
+325,999
| +8% | +$15M |
|
|
MRSH
215
Marsh
MRSH
$90B
| $237M | 0.08% |
3,512,942
-70,525
| -2% | -$4.73M |
|
|
K
216
DELISTED
Kellanova
K
| $231M | 0.07% |
3,339,581
-149
| -0% | -$10.4K |
|
217
Ralph Lauren
RL
$23.1B
| $230M | 0.07% |
2,550,003
| – | – |
|
218
Boston Scientific
BSX
$74.8B
| $229M | 0.07% |
10,570,006
+4
| +0% | +$87 |
|
|
CHK
219
DELISTED
Chesapeake Energy Corporation
CHK
| $228M | 0.07% |
162,364
-1,979
| -1% | -$2.59M |
|
|
IPHI
220
DELISTED
INPHI CORPORATION
IPHI
| $218M | 0.07% |
4,883,834
| – | – |
|
221
KKR & Co
KKR
$102B
| $218M | 0.07% |
14,135,660
+4,003,190
| +40% | +$60.4M |
|
222
Vale
VALE
$59.4B
| $215M | 0.07% |
28,215,166
-983
| -0% | -$7.2K |
|
|
CRZO
223
DELISTED
Carrizo Oil & Gas Inc
CRZO
| $212M | 0.07% |
5,676,973
| – | – |
|
|
CTRA
224
DELISTED
Coterra Energy
CTRA
| $207M | 0.07% |
8,840,000
-20,529,388
| -70% | -$462M |
|
225
Insulet
PODD
$9.95B
| $204M | 0.07% |
5,411,633
+236,600
| +5% | +$8.81M |
|
Similar funds
Capital Research Global Investors's Q4 2016 Portfolio in Review
As of Q4 2016, Capital Research Global Investors held 465 positions worth $308B, up 2% from $303B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Capital Research Global Investors's Q4 2016 filing shows 52 new, 126 increased, 139 reduced and 38 closed positions. Its largest new stake was Broadcom: 317,484,320 shares worth $5.61B. The largest sale was Amgen, an estimated $2.02B.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, down from 19% a quarter earlier, followed by Technology and Financials.
- Capital Research Global Investors's largest Q4 2016 buy was Broadcom: 317,484,320 shares worth $5.61B.
- Capital Research Global Investors added most to JPMorgan Chase in Q4 2016, an estimated $1.33B increase.
- Capital Research Global Investors's biggest Q4 2016 reduction was Amgen, cutting an estimated $2.02B.
- Capital Research Global Investors fully exited Digital Realty Trust in Q4 2016, selling an estimated $1.33B.
- Capital Research Global Investors's ten largest holdings make up 23% of its $308B portfolio in Q4 2016.
- Capital Research Global Investors opened 52 new positions and closed 38 in Q4 2016.
- Capital Research Global Investors's portfolio value rose 2% quarter-over-quarter to $308B.
Based on Capital Research Global Investors's 13F filing for Q4 2016, filed 15 Feb 2017.